BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 20036233)

  • 1. Sdc1 negatively modulates carcinoma cell motility and invasion.
    Ishikawa T; Kramer RH
    Exp Cell Res; 2010 Apr; 316(6):951-65. PubMed ID: 20036233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syndecan-1 and -4 differentially regulate oncogenic K-ras dependent cell invasion into collagen through α2β1 integrin and MT1-MMP.
    Vuoriluoto K; Högnäs G; Meller P; Lehti K; Ivaska J
    Matrix Biol; 2011 Apr; 30(3):207-17. PubMed ID: 21414405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G alpha 12 inhibits alpha2 beta1 integrin-mediated Madin-Darby canine kidney cell attachment and migration on collagen-I and blocks tubulogenesis.
    Kong T; Xu D; Yu W; Takakura A; Boucher I; Tran M; Kreidberg JA; Shah J; Zhou J; Denker BM
    Mol Biol Cell; 2009 Nov; 20(21):4596-610. PubMed ID: 19776354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syndecan-1-Induced ECM Fiber Alignment Requires Integrin αvβ3 and Syndecan-1 Ectodomain and Heparan Sulfate Chains.
    Yang N; Friedl A
    PLoS One; 2016; 11(2):e0150132. PubMed ID: 26909794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syndecan-1 couples the insulin-like growth factor-1 receptor to inside-out integrin activation.
    Beauvais DM; Rapraeger AC
    J Cell Sci; 2010 Nov; 123(Pt 21):3796-807. PubMed ID: 20971705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrin engagement differentially modulates epithelial cell motility by RhoA/ROCK and PAK1.
    Zhou H; Kramer RH
    J Biol Chem; 2005 Mar; 280(11):10624-35. PubMed ID: 15611088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syndecan-1 supports integrin alpha2beta1-mediated adhesion to collagen.
    Vuoriluoto K; Jokinen J; Kallio K; Salmivirta M; Heino J; Ivaska J
    Exp Cell Res; 2008 Nov; 314(18):3369-81. PubMed ID: 18657535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syndecan-1 regulates cell migration and fibronectin fibril assembly.
    Stepp MA; Daley WP; Bernstein AM; Pal-Ghosh S; Tadvalkar G; Shashurin A; Palsen S; Jurjus RA; Larsen M
    Exp Cell Res; 2010 Aug; 316(14):2322-39. PubMed ID: 20580707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syndecan-1 in breast cancer stroma fibroblasts regulates extracellular matrix fiber organization and carcinoma cell motility.
    Yang N; Mosher R; Seo S; Beebe D; Friedl A
    Am J Pathol; 2011 Jan; 178(1):325-35. PubMed ID: 21224069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of tumour-suppressing chemokine BRAK/CXCL14 reduces cell migration rate of HSC-3 tongue carcinoma cells and stimulates attachment to collagen and formation of elongated focal adhesions in vitro.
    Sato K; Ozawa S; Izukuri K; Kato Y; Hata R
    Cell Biol Int; 2010 Apr; 34(5):513-22. PubMed ID: 20067447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of primary fibroblasts and keratinocytes with extracellular matrix proteins: contribution of alpha2beta1 integrin.
    Zhang ZG; Bothe I; Hirche F; Zweers M; Gullberg D; Pfitzer G; Krieg T; Eckes B; Aumailley M
    J Cell Sci; 2006 May; 119(Pt 9):1886-95. PubMed ID: 16636073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression.
    Nikolova V; Koo CY; Ibrahim SA; Wang Z; Spillmann D; Dreier R; Kelsch R; Fischgräbe J; Smollich M; Rossi LH; Sibrowski W; Wülfing P; Kiesel L; Yip GW; Götte M
    Carcinogenesis; 2009 Mar; 30(3):397-407. PubMed ID: 19126645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syndecan-1 and -4 influence Wnt signaling and cell migration in human breast cancers.
    Pham SH; Pratt K; Okolicsanyi RK; Oikari LE; Yu C; Peall IW; Arif KT; Chalmers TA; Gyimesi M; Griffiths LR; Haupt LM
    Biochimie; 2022 Jul; 198():60-75. PubMed ID: 35183674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmembrane and extracellular domains of syndecan-1 have distinct functions in regulating lung epithelial migration and adhesion.
    Altemeier WA; Schlesinger SY; Buell CA; Brauer R; Rapraeger AC; Parks WC; Chen P
    J Biol Chem; 2012 Oct; 287(42):34927-34935. PubMed ID: 22936802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of Rac and Rho signaling in cancer cell motility in 3D substrates.
    Yamazaki D; Kurisu S; Takenawa T
    Oncogene; 2009 Apr; 28(13):1570-83. PubMed ID: 19234490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enoxaparin improves the course of dextran sodium sulfate-induced colitis in syndecan-1-deficient mice.
    Floer M; Götte M; Wild MK; Heidemann J; Gassar ES; Domschke W; Kiesel L; Luegering A; Kucharzik T
    Am J Pathol; 2010 Jan; 176(1):146-57. PubMed ID: 20008145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syndecan-1 and Syndecan-4 Capture Epidermal Growth Factor Receptor Family Members and the α3β1 Integrin Via Binding Sites in Their Ectodomains: NOVEL SYNSTATINS PREVENT KINASE CAPTURE AND INHIBIT α6β4-INTEGRIN-DEPENDENT EPITHELIAL CELL MOTILITY.
    Wang H; Jin H; Rapraeger AC
    J Biol Chem; 2015 Oct; 290(43):26103-13. PubMed ID: 26350464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrin alpha2beta1 modulates EGF stimulation of Rho GTPase-dependent morphological changes in adherent human rhabdomyosarcoma RD cells.
    Leabu M; Uniyal S; Xie J; Xu YQ; Vladau C; Morris VL; Chan BM
    J Cell Physiol; 2005 Mar; 202(3):754-66. PubMed ID: 15481063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoplasmic domain interactions of syndecan-1 and syndecan-4 with α6β4 integrin mediate human epidermal growth factor receptor (HER1 and HER2)-dependent motility and survival.
    Wang H; Jin H; Beauvais DM; Rapraeger AC
    J Biol Chem; 2014 Oct; 289(44):30318-30332. PubMed ID: 25202019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-494 acts as a tumor suppressor in pancreatic cancer, inhibiting epithelial-mesenchymal transition, migration and invasion by binding to SDC1.
    Yang Y; Tao X; Li CB; Wang CM
    Int J Oncol; 2018 Sep; 53(3):1204-1214. PubMed ID: 29956739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.